Parexel International (Newton, MA) is a leading global clinical CRO. 2024 revenue ~$4B. BioPharma services, clinical pharmacology, regulatory consulting. Taken private by EQT/PPF (2022). Focus on oncology and rare disease trials.
12:41:31 AM · Jul 9, 2026